Health System

A study presented during PAINWeek 2020 Live Virtual Conference highlights the role of e-consultations in reducing opioid use.

“This first-generation polypill is not magic, but it would be clinically worthwhile.”

Many opportunities exist for pharmacists within the multidisciplinary care team to ensure the delivery of optimal cancer care.

Shared information and continued communication can build a cohesive partnership.

A webcast hosted by the Association of Black Cardiologists addresses barriers to enhancing diversity in medicine and identifies the potential solutions.

Controlling exposure to antibiotics is important for stewardship programs, and even more so in neonatal intensive care units.

The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.

Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.

Bill SB 852 would address the affordability and accessibility of generic drugs, including insulin and epinephrine, in California.

Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.

The Assure test is the only FDA authorized COVID-19 point-of-care serology test.

Pharmacists, nurses, and physicians work together to combat the overuse of powerful pain relievers.

Early data from a phase 3 trial showed that baricitinib combined with remdesivir improved recovery in patients hospitalized with COVID-19 compared with remdesivir alone.

Here's this week's coronavirus-related news you should know.

The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.

Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.

Here's the coronavirus-related news from this week that you should know.

ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.

The removal of the boxed warning from canagliflozin was based on the FDA’s review of new data from 3 clinical trials.

Amisuplride injection (Barhemsys; Acacia) is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis with an agent of a different class.

An examination of how telehealth services for medically underserved patients in rural areas improve access to pharmacists for chronic care management.

Here's this week's coronavirus-related news that you should know.

Results of the study demonstrated conclusive evidence of drug dose gender gaps from 86 different FDA-approved medications.

Two senior administration officials from Operation Warp Speed offered the latest updates on COVID-19 vaccine development.

Here's the coronavirus-related news from this week that you should know.

The COVID-19 crisis poses unique challenges for managing controlled substances in hospitals.

The opioid’s indication was based on several randomized controlled trials, where patients reported decreased pain.

Here's this week's coronavirus-related news you should know.

The grants are part of the administration’s continuing focus on rural health initiatives.

ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.